Clinical trial
Best Biliary Drainage Option in Type II、III、IV Klatskin Tumor:ERCP or PTBD
NCT03104582 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Best Biliary Drainage Option in Type II、III、IV Klatskin Tumor:ERCP or PTBD
- Lead sponsor
- Hepatopancreatobiliary Surgery Institute of Gansu Province
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2011
- Completion date
- July 14, 2017
- Enrollment
- 180 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.